Quantitative Assessment of Visual Field Recovery Following Transspheniodal Pituitary Adenoma Excision and its Time Course
Article Sidebar
Main Article Content
Abstract
Background: Pituitary adenomas are a significant subset of intracranial tumors, constituting approximately 10-15% of all primary brain tumors. These benign tumors often lead to various clinical symptoms, including hormonal imbalances and visual field defects due to optic chiasm compression. The transsphenoidal approach for pituitary adenoma excision is favored for its minimal invasiveness and favorable outcomes. However, the timeline and extent of visual field recovery post-surgery remain areas of active research.
Objective: This study aimed to quantitatively assess and track visual field recovery in patients following transsphenoidal pituitary adenoma excision and to identify factors influencing the recovery process.
Methods: This descriptive observational study was conducted at the Department of Neurosurgery, Pakistan Institute of Medical Sciences (PIMS), Islamabad, from June 16, 2023, to March 31, 2024. Forty-six consecutive patients, aged 18-70 years, who underwent transsphenoidal pituitary adenoma excision and had documented visual field impairments, were included. Exclusion criteria were previous pituitary surgery, pre-existing visual field abnormalities not attributable to pituitary adenoma, and inability to perform visual field testing. Preoperative visual field measurements were taken within two weeks before surgery using Humphrey visual field testing. Postoperative evaluations were performed immediately after surgery (within 48 hours), and at one month, two months, and three months. Visual field indices, including mean deviation (MD) and pattern standard deviation (PSD), were recorded. Data were analyzed using SPSS version 25, with descriptive statistics for patient demographics and tumor characteristics, and inferential statistics (Student's t-test and chi-square test) for comparing visual field indices.
Results: The study included 23 male and 23 female patients, with a mean age of 52.3 years (SD ± 8.7). Tumor size averaged 2.7 cm (SD ± 0.9). Non-functioning tumors comprised 65.2% of cases. Preoperative hormonal dysfunction was present in 39.1% of patients. Preoperative visual field indices showed a mean MD of -5.2 dB (SD ± 2.1). Visual field improvement was noted postoperatively, with mean MD values of -4.0 dB (SD ± 1.8) at 48 hours, -3.5 dB (SD ± 1.7) at one month, -2.8 dB (SD ± 1.5) at two months, and -2.2 dB (SD ± 1.3) at three months. Endoscopic surgery was performed in 82.6% of cases, with a gross total resection rate of 69.6%. Postoperative complications included CSF leaks (13%) and hypopituitarism (26.1%).
Conclusion: The study demonstrated significant visual field recovery in patients following transsphenoidal pituitary adenoma excision, with notable improvements observed within the first three months post-surgery. These findings support the efficacy of the transsphenoidal approach in improving visual outcomes and highlight the importance of early intervention and comprehensive postoperative monitoring.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Gittleman H, Ostrom QT, Farah PD, Ondracek A, Chen Y, Wolinsky Y, Kruchko C, Singer J, Kshettry VR, Laws ER, Sloan AE. Descriptive Epidemiology of Pituitary Tumors in the United States, 2004–2009. Journal of Neurosurgery. 2014;121(3):527-35.
Ntali G, Wass JA. Epidemiology, Clinical Presentation and Diagnosis of Non-Functioning Pituitary Adenomas. Pituitary. 2018;21:111-8.
Asha MJ, Oswari S, Takami H, Velasquez C, Almeida JP, Gentili F. Craniopharyngiomas: Challenges and Controversies. World Neurosurgery. 2020;142:593-600.
Elder JB, Sherman JH, Prevedello DM, Szerlip NJ, Spratt DE, Shaikhouni A, Mohyeldin A, Perez-Roman RJ, Buttrick SS, Ali SC, Komotar RJ. Tumor. Operative Neurosurgery. 2019;17(Supplement_1)
Avery RA. Visual Loss: Disorders of the Chiasm. In: Liu, Volpe, and Galetta's Neuro-Ophthalmology. Elsevier; 2019. p. 237-91.
Couldwell WT. Transsphenoidal and Transcranial Surgery for Pituitary Adenomas. Journal of Neuro-Oncology. 2004;69:237-56.
Cappabianca P, Alfieri A, Colao A, Cavallo LM, Fusco M, Peca C, Lombardi G, de Divitiis E. Endoscopic Endonasal Transsphenoidal Surgery in Recurrent and Residual Pituitary Adenomas. Minimally Invasive Neurosurgery. 2000;43(01):38-43.
Castle-Kirszbaum M, Wang YY, King J, Goldschlager T. Predictors of Visual and Endocrine Outcomes After Endoscopic Transsphenoidal Surgery for Pituitary Adenomas. Neurosurgical Review. 2022;1-1.
Luomaranta T, Raappana A, Saarela V, Liinamaa MJ. Factors Affecting the Visual Outcome of Pituitary Adenoma Patients Treated With Endoscopic Transsphenoidal Surgery. World Neurosurgery. 2017;105:422-31.
Gnanalingham KK, Bhattacharjee S, Pennington R, Ng J, Mendoza N. The Time Course of Visual Field Recovery Following Transsphenoidal Surgery for Pituitary Adenomas: Predictive Factors for a Good Outcome. Journal of Neurology, Neurosurgery & Psychiatry. 2005;76(3):415-9.
Leitner MC, Hutzler F, Schuster S, Vignali L, Marvan P, Reitsamer HA, Hawelka S. Eye-Tracking-Based Visual Field Analysis (EFA): A Reliable and Precise Perimetric Methodology for the Assessment of Visual Field Defects. BMJ Open Ophthalmology. 2021;6(1)
Serioli S, Doglietto F, Fiorindi A, Biroli A, Mattavelli D, Buffoli B, Ferrari M, Cornali C, Rodella L, Maroldi R, Gasparotti R. Pituitary Adenomas and Invasiveness From Anatomo-Surgical, Radiological, and Histological Perspectives: A Systematic Literature Review. Cancers. 2019;11(12):1936.
Singh S, Chani PS. Thermal Comfort Analysis of Indian Subjects in Multi-Storeyed Apartments: An Adaptive Approach in Composite Climate. Indoor and Built Environment. 2018;27(9):1216-46.
García-Marqueta M, Vázquez M, Krcek R, Kliebsch UL, Baust K, Leiser D, van Heerden M, Pica A, Calaminus G, Weber DC. Quality of Life, Clinical, and Patient-Reported Outcomes After Pencil Beam Scanning Proton Therapy Delivered for Intracranial Grade WHO 1–2 Meningioma in Children and Adolescents. Cancers. 2023;15(18):4447.
Lobatto DJ, Zamanipoor Najafabadi AH, de Vries F, Andela CD, van den Hout WB, Pereira AM, Peul WC, Vliet Vlieland TP, van Furth WR, Biermasz NR. Toward Value-Based Health Care in Pituitary Surgery: Application of a Comprehensive Outcome Set in Perioperative Care. European Journal of Endocrinology. 2019;181(4):375-87.
Alba EL, Japp EA, Fernandez-Ranvier G, Badani K, Wilck E, Ghesani M, Wolf A, Wolin EM, Corbett V, Steinmetz D, Skamagas M. The Mount Sinai Clinical Pathway for the Diagnosis and Management of Hypercortisolism Due to Ectopic ACTH Syndrome. Journal of the Endocrine Society. 2022;6(7)